SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-23-119813
Filing Date
2023-11-20
Accepted
2023-11-20 12:08:01
Documents
1
Period of Report
2023-11-20

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2331068-3_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2331068-3_4seq1.xml 4 5819
  Complete submission text file 0001104659-23-119813.txt   7313
Mailing Address 616 N. NORTH COURT, SUITE 120 . PALATINE IL 60067
Business Address 616 N. NORTH COURT, SUITE 120 PALATINE IL 60067 847-705-7709
ACURA PHARMACEUTICALS, INC (Issuer) CIK: 0000786947 (see all company filings)

IRS No.: 110853640 | State of Incorp.: NY | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ACURA PHARMACEUTICALS, INC. 616 N NORTH COURT PALATINE IL 60067
Business Address
Jones Robert B (Reporting) CIK: 0001431759 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-10113 | Film No.: 231421704